945954-94-9

Basic information

• Product Name: Methyl 6-broMo-3-Methoxypicolinate
• Synonyms: Methyl 6-broMo-3-Methoxypicolinate
• CAS NO: 945954-94-9
• Molecular Formula: C8H8BrNO3
• Molecular Weight: 246.05802
• Mol File: 945954-94-9.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 338.2±37.0 °C(Predicted)
• Appearance: /
• Density: 1.530±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -1.56±0.10(Predicted)
• CAS DataBase Reference: Methyl 6-broMo-3-Methoxypicolinate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 6-broMo-3-Methoxypicolinate(945954-94-9)
• EPA Substance Registry System: Methyl 6-broMo-3-Methoxypicolinate(945954-94-9)

Safety Data

• Hazardous Substances Data: 945954-94-9(Hazardous Substances Data)

Usage

General Description

Methyl 6-brom0-3-methoxypicolinate is a chemical compound with the molecular formula C8H8BrNO3. It is also known as 6-bromo-3-methoxynicotinic acid methyl ester and is a derivative of nicotinic acid. Methyl 6-broMo-3-Methoxypicolinate is used in chemical research and has potential applications in pharmaceuticals and agrochemicals. It is a white to off-white solid with a characteristic odor, and it is soluble in organic solvents such as ethanol and methanol. Methyl 6-bromo-3-methoxypicolinate is classified as a hazardous substance, and proper safety precautions must be taken when handling and storing it.

Upstream product

• 1256810-26-0 6-bromo-3-methoxypyridine-2-carboxylic acid 
• 74-88-4 methyl iodide 
• 62733-99-7 methyl 3-hydroxypicolinate 
• 874-24-8 3-hydroxypyridine-2-carboxylic acid 
• 16478-52-7 3-methoxypyridine-2-carboxylic acid 
• 24059-83-4 3-methoxypyridine-2-carboxylic acid methyl ester 
• 321601-48-3 methyl 6-bromo-3-hydroxypyridine-2-carboxylate 
• 186581-53-3 diazomethane 

Downstream Products

• 1349179-60-7 C₁₈H₁₈BrF₂N₃O₄S 
• 1214330-74-1 3-methoxy-6-(trifluoromethyl)picolinic acid 
• 945954-95-0 6-bromo-3-methoxypicolinaldehyde 
• 1256810-26-0 6-bromo-3-methoxypyridine-2-carboxylic acid 

Relevant articles and documents

ROR-GAMMA INHIBITORS

The present invention relates to compounds of formula I and pharmaceutical compositions comprising compounds of formula I. Compounds of Formula I are useful in treatment of inflammatory, metabolic or autoimmune diseases which are mediated by RORy.

TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C

The present invention relates to compounds of formula I that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

Disclosed are compounds of formula (I) that are useful as hepatitis C virus (HCV) NSSB polymerise inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NSSB polymerise activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.